P1.07.49 Limited Impact of Adjuvant Chemotherapy in Alk-Positive Stage II-III Adenocarcinoma: A Multicenter CReGYT-03 ALK Study
Akira Hamada(Kindai University), Y. Tsutani(Kindai University), K. Kosai(National Hospital Organization Kyushu Cancer Center), Yasuhisa Ohde(Shizuoka Cancer Center), Masatomo Yoshikawa(Okayama University Hospital), Miyuki Abe(Oita University), Y. Shimada(Tokyo Medical University), M. Shimokawa(Yamaguchi University), S Tane(Kobe University), T.A. Fukami(Rokko Island Kohnan Hospital), J. Soh(Osaka City University), S. Shiono(Yamagata University), Keiichi Hara(Osaka City University), Kazuki Takada(Saiseikai Fukuoka General Hospital), S. Ohara(Kindai University), Satoshi Muto(Fukushima Medical University), Ken Suzawa(Okayama University), Rumi Fujikawa(Shizuoka Medical Center), Hirotsugu Notsuda(Tohoku University), N. Haratake(Oita University), Kenichi Suda(Izumi City General Hospital), Koichi Nomura(National Cancer Center Hospital East), Tatsuaki Matsubara(Aichi Mizuho College), K. Hayasaka(Shizuoka Cancer Center), Hiroshi Hoshino(United States Naval Hospital Okinawa), Shinkichi Takamori(Oita University), Atsushi Kamigaichi(Hiroshima University), Hiroshi Watanabe(Tohoku University), Tatsunori Nishimura, Tetsuya Toyoda(Chiba University), Hiroyuki Oiki(Kindai University), S. Wakasu(National Kyushu Medical Center), K. Shien(Okayama University Hospital), Asato Hashinokuchi(National Hospital Organization Kyushu Cancer Center), Michihito Toda(Japan Organization of Occupational Health and Safety), Satoshi Okada(The University of Tokyo), Kosuke Fujino(Kumamoto University), T. Koga(University Health Network), Shota Fukuda(Kindai University), Masanori Ito(Kindai University), S. Matsuo(Nihonkai General Hospital), Kazuhiro Minegishi(Jichi Medical University), Shinya Katsumata(Shizuoka Cancer Center), T. Watanabe(Seirei Mikatabara General Hospital), J. Suzuki(Yamagata University), Makoto Endo(Yamagata Prefectural Central Hospital), Keigo Sekihara(Shizuoka University)
Cited by 0
Related Papers
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
|Nature Genetics|2013|550
Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations
|Journal of Clinical Oncology|2006|504
Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer
|American Journal Of Pathology|2015|140
Interethnic analyses of blood pressure loci in populations of East Asian and European descent
|Nature Communications|2018|129
Multicenter study of autoimmune gastritis in Japan: Clinical and endoscopic characteristics
|Digestive Endoscopy|2019|127